Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Qvarfordt (Uppsala, Sweden), A. Sanchez-Crespo (Stockholm, Sweden), M. Anderson (Stockholm, Sweden), M. Diakopolou (Stockholm, Sweden), M. Svartengren (Uppsala, Sweden). Patients with idiopathic pulmonary fibrosis and chronic obstructive lung disease leak inhaled nanoparticles to the blood.. 2442

Member's Comments

No comment yet.

Related content which might interest you: A comparison of 99mTc-DTPA clearance and translocation of nano particles in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Systemic inflammation in chronic obstructive pulmonary disease in patients with pulmonary hypertension Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysema: hemodynamic severity Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018 Immunological profiling of chronic obstructive airways disease and idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Systemic and pulmonary inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Pathophysiology of COPD Year: 2008 Influence of bronchodilators on pulmonary hypertension in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2003; 22: Suppl. 45, 427s Year: 2003 Variability in expression of aquoporine 1 in chronic obstructive pulmonary disease and interstitial lung disease patients Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 Large airways remodeling in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2008 - Pathophysiology of respiratory diseases Year: 2008 Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Source: Eur Respir J 2010; 35: 105-111 Year: 2010 Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Disease of the airways in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 41S-49S Year: 2001 Platelet characteristics of patients with chronic obstructive pulmonary disease (COPD) accompanied with lung hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 226s Year: 2007 Analysis of pulmonary function and obstructive sleep apnea in patients with COPD, asthma and idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Noninvasive ventilation in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis Source: Eur Respir J 2002; 20: 777-784 Year: 2002 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Is the severity of oxidative stress different in patients with end stage chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) waiting for lung transplantation? Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Chronic obstructive pulmonary disease with preserved lung function, severe hypoxemia and emphysema Source: Virtual Congress 2020 – Monitoring of patients with COPD Year: 2020